Atlas Trials

The Evaluation of Bioequivalence Between a Single-dose Pen and a Multi-dose Pen of HRS9531 Injection Solution

Clinical trial NCT06792955 · COMPLETED

Trial details

NCT number
NCT06792955
Sponsor
Fujian Shengdi Pharmaceutical Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Overweight/Obesity
Start date
2025-02-11
Primary completion
2025-06-06
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.